• Campus Access
  • About MPG.eBooks
Skip to content
Search Tips
  • Home>
  • Patient group input submission...
  • Description
Language
  • Advanced
Cover Image
Read Now

Patient group input submissions: Canagliflozin and metformin hydrochloride (Invokamet) for type 2 diabetes

Bibliographic Details
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Diabetes Association, Kidney Foundation of Canada
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, 2018
Series:CADTH common drug review
Online Access:
https://www.ncbi.nlm.nih.gov/books/NBK540343
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to MARC
    • Export to BibTeX
  • Description
  • Staff View
Description
Physical Description:1 PDF file (11 pages)

Similar Items

  • Patient group input submissions: Canagliflozin and metformin hydrochloride (Invokamet) for type 2 diabetes
    Published: (2018)
  • CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
    Published: (2016)
  • CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
    Published: (2016)
  • Patient group input submissions: Empagliflozin and metformin (Synjardy) for diabetes mellitus (Type 2)
    Published: (2017)
  • Patient group input submissions: Empagliflozin and metformin (Synjardy) for diabetes mellitus (Type 2)
    Published: (2017)
Logo Max Planck Digital Library
  • Advanced Search
  • Recently Uploaded
  • Search History
  • Disclaimer
  • Privacy Policy
  • Cookie Settings
  • Contact
Loading...